Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens.
Although effective polysaccharide vaccines have been developed for meningococcal groups A, C, Y, and W135, the purified group B polysaccharide has proven to be nonimmunogenic. Earlier studies indicated that serotype 2 outer membrane protein vaccines induced bactericidal antibodies in animals and pro...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Infect Immun |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society for Microbiology (ASM)
1982
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC347523/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6809629/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.37.1.271-280.1982 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|